Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


David Price

David Price, Pleasanton, CA US

Patent application numberDescriptionPublished
20080234943COMPUTER PROGRAM FOR DIABETES MANAGEMENT - A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large amount of blood glucose concentration measurements and other physiological parameters related to the glycemia of a patient. In particular, a method of monitoring glycemia in a patient may include storing a patient's data on a suitable device, such as, for example, a glucose meter. The patient's data may include blood glucose concentration measurements. The diabetes management system or process may be installed on, but is not limited to, a personal computer, an insulin pen, an insulin pump, or a glucose meter. The diabetes management system or process may identify a plurality of pattern types from the data including a testing/dosing pattern, a hypoglycemic pattern, a hyperglycemic pattern, a variability pattern, and a comparative pattern. After identifying a particular pattern with the data management system or process, a warning message may be displayed on a screen of a personal computer or a glucose meter. Other messages can also be provided to ensure compliance of any prescribed diabetes regiments or to guide the patient in managing the patient's diabetes.09-25-2008
20080234992SYSTEMS AND METHODS FOR PATTERN RECOGNITION IN DIABETES MANAGEMENT - A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large number of blood glucose concentration measurements and other physiological parameters related to the glycemia of a patient. In particular, a method of monitoring glycemia in a patient may include storing a patient's data on a suitable device, such as, for example, a blood glucose meter. The patient's data may include blood glucose concentration measurements. The diabetes management system or process may be installed on, but is not limited to, a personal computer, an insulin pen, an insulin pump, or a glucose meter. The diabetes management system or process may identify a plurality of pattern types from the data including a testing/dosing pattern, a hypoglycemic pattern, a hyperglycemic pattern, a blood glucose variability pattern, and a comparative pattern. After identifying a particular pattern with the data management system or process, a warning message may be displayed on a screen of a personal computer or a glucose meter. Other messages can also be provided to ensure compliance of any prescribed diabetes regiments or to guide the patient in managing the patient's diabetes.09-25-2008
20080235053COMMUNICATION MEDIUM FOR DIABETES MANAGEMENT - A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large amount of blood glucose concentration measurements and other physiological parameters related to the glycemia of a patient. In particular, a communication medium is provided. The communication medium includes first, second, third, fourth and fifth display areas. The second through fifth display areas can be disposed in the first display area. The second display area has identification information of a patient. The third display area has a plurality of textual messages indicative of glycemic status of the patient. The fourth display area includes a chart indicative of a variability of the glucose concentration of the patient over a predetermined time period. Other messages can also be provided to ensure compliance of any prescribed diabetes regiments or to guide the patient in managing the patient's diabetes.09-25-2008
20100016700ANALYTE MEASUREMENT AND MANAGEMENT DEVICE AND ASSOCIATED METHODS - Various embodiments of a diabetes management system are provided. One exemplary system may include an analyte measurement device and a therapeutic agent delivery device. The measurement device includes a measurement unit, display, and first wireless module. The therapeutic agent delivery device has a delivery device housing, delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider, and a second wireless module. The second module, automatically, without prompting from a user or any active input or action by the user, transmits a signal to the first wireless module indicative of: (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user; or (c) type of therapeutic agent device from which the therapeutic agent was administered. Also described are diabetes management devices and methods.01-21-2010
20100332142ANALYTE TESTING METHOD AND DEVICE FOR CALCULATING BASAL INSULIN THERAPY - Described herein are various methods to ensure safety and the compliance of therapeutic diabetes protocols. The method can be achieved by performing safeguards against hypoglycemia of the user prior to any change in basal insulin dosage based on the plurality of data.12-30-2010
20110077493ANALYTE TESTING METHOD AND DEVICE FOR DIABETES MANGEMENT - Various embodiments are described and illustrated to calculate an insulin bolus, recommend such bolus, and provide reminder messages for performing an additional glucose test.03-31-2011
20110184653ANALYTE TESTING METHOD AND SYSTEM - Various methods and systems to manage diabetes using data relating to testing compliance, bolus dosing, or cannula usage are described and illustrated.07-28-2011
20110205064ANALYTE TESTING METHOD AND SYSTEM WITH HIGH AND LOW BLOOD GLUCOSE TRENDS NOTIFICATION - Described herein are systems and methods to utilize factual information based on stored blood glucose data to allow greater insight into the management of diabetes of a user.08-25-2011
20110245634Methods, Systems, and Devices for Analyzing Patient Data - Described herein is a method of analyzing an analyte distribution from discrete, quasi-continuous or continuous measurements to determine a glycemic state of a patient in order to understand how often, and for how long, a patient's post-prandial glucose is out of control without requiring laboratory blood test and especially post-prandial levels laboratory analysis. The systems, devices, and methods assist in predicting risk levels of developing diabetes-associated complications. Therefore applicants have recognized also a need for a tool which facilitates stratification of patients for risk of and/or onset of one or more complications having the same HbA1c level.10-06-2011

Patent applications by David Price, Pleasanton, CA US

David Price, Miami, OK US

Patent application numberDescriptionPublished
20110067648PET HARNESS SAFETY SYSTEM - A pet harness safety system has a harness assembly with two parallel body loops and a carabiner tether assembly with opposing carabiners. During usage, one of the carabiners is secured to a reinforced loop on each of the body loops of the harness assembly and the other carabiner is secured to an in-vehicle restraint system. The body loops are substantially parallel to the body of the dog such that only its shoulders are encircled by the body loops, and are adjustably joined together to form a completed or closed system.03-24-2011

David Price, Littleover GB

Patent application numberDescriptionPublished
20080269093Antiwear Polymer and Lubricating Composition Thereof - The present invention relates to the use of a RAFT polymer as an antiwear agent in a lubricant. The lubricant may be useful in a number of mechanical devices.10-30-2008
20090305923Dispersant Viscosity Modifiers Based on Maleic Anhydride-Styrene Copolymers - An interpolymer composition comprising monomer-derived units of (i) at least one of an aliphatic olefin containing from 2 to 30 carbon atoms and a vinyl aromatic monomer, and (ii) at least one alpha, beta-unsaturated acylating agent; wherein a portion of said acylating agent monomers is esterified and wherein a portion of said acylating agent monomers is condensed with at least one aromatic amine, provides good viscosity modification and dispersancy performance.12-10-2009
20100144566Lubricant Compositions - The present invention relates to a lubricating composition containing (a) an ester-containing viscosity index improver; and (b) a polyoxyalkylene polyol. The invention further provides a method for lubricating a mechanical device with the lubricating composition.06-10-2010
20100212624Method of Viscosity Control - This invention relates to a method of lubricating an internal combustion engine comprising at least one of a crankcase, a gear and a wet-clutch, said method comprising supplying to said crankcase, gear and wet-clutch a lubricating composition comprising: (a) an oil of lubricating viscosity; and (b) a viscosity modifier with a number average molecular weight from 1000 to 75,000, wherein the lubricating composition has a SAE viscosity grade from XW-Y, wherein X is from 0 to 20 and Y is from 20 to 50; and wherein the lubricating composition has a phosphorus content from a metal hydrocarbyl dithiophosphate of 0.12 wt % or less.08-26-2010
20110059881Sulphur Free Composition And Lubricant Composition And Methods Thereof - A composition comprises a sulphur free reaction product of: (a)(i) a hydrocarbyl substituted aromatic compound containing an acidic group selected from the group consisting of a carboxylic group, a hydroxyl group and mixtures thereof; and (a)(ii) an organic nitrogen-containing base reacted with the acidic group. The composition is obtained by a preparatory process and is useful in a method for lubricating an internal combustion engine to include where the lubricant has reduced levels of sulphur, phosphorus and sulphated ash.03-10-2011

Patent applications by David Price, Littleover GB

David Price, Derbyshire GB

Patent application numberDescriptionPublished
20090298729Star Polymer Lubricating Composition - The invention provides a lubricating composition containing (a) 0.001 wt % to 15 wt % of a polymer with radial or star architecture; (b) an overbased detergent; (c) a dispersant; and (d) an oil of lubricating viscosity. The invention further provides a method for lubricating a mechanical device with the lubricating composition.12-03-2009
20100152082Polymer and Lubricating Compositions Thereof - The invention provides a lubricating composition containing an oil of lubricating viscosity and a hydrogenated copolymer of an olefin block and vinyl aromatic block, wherein the copolymer is optionally functionalised. The invention further provides a method for preparing a hydrogenated copolymer; and the use of the lubricating composition.06-17-2010

Patent applications by David Price, Derbyshire GB

David Price, Reading GB

Patent application numberDescriptionPublished
20090314193Ultra-Sonic Device - The present invention relates to an ultra-sonic device, which can be utilised in an aquatic environment to inhibit growth of waterborne flora and fauna. In particular, the present invention relates to a method of reducing such growth and the removal from the underside of yachts, boats and the like. In general, the present invention relates to anti-fouling systems as are known to prevent biological growth such as algae, seaweed and crustacea on marine vessels or underwater structures. Coating materials have been developed preventing corrosion due to oxidation of the surface of the structure. Although such materials have effects of retarding growth of the corrosion, however, they contain zinc, lead, copper, etc, raising a problem of environmental pollution due to dissolution of these metals into seawater. In addition, none of these coating materials can prevent clinging of marine organisms, and if they cling to the structure, oxidation is accelerated by oxygen sent out from the marine organisms, causing further growth of the corrosion of the structure. The formation of encrustations of barnacles, tunicates, and like fouling organisms, will increase the vessel's weight, thereby decreasing the available storage space, slow a vessel underway, increase its fuel consumption, and make it difficult to handle, thus reducing the vessel's performance and efficiency. The present invention addresses this need wherein the transducer is operable on a cyclic basis.12-24-2009

Patent applications by David Price, Reading GB

David Price, Belper GB

Patent application numberDescriptionPublished
20110190182Novel Copolymers and Lubricating Compositions Thereof - The present invention relates to a copolymer comprising units derived from monomers (i) an α-olefin and (ii) an ethylenically unsaturated carboxylic acid or derivatives thereof esterified with a primary alcohol branched at the β- or higher position, wherein the copolymer has a reduced specific viscosity of up to 0.08. The invention further provides for a lubricating composition containing said copolymer. The invention further provides a method and use of controlling viscosity index by supplying to an oil of lubricating viscosity the copolymer with pendant groups. In addition, the copolymer of the present invention may be useful as a base oil replacement.08-04-2011

David Price, Aylsham GB

Patent application numberDescriptionPublished
20110212137INHALABLE PHARMACEUTICAL COMPOSITION - An inhalable pharmaceutical solution aerosol comprising beclometasone dipropionate, ethanol and a propellant selected from 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoropropane and a mixture thereof, wherein the aerosol has a droplet size having a mass median aerodynamic diameter of 0.5-2.0 μm, for maintaining lung function above 60% of baseline FEV09-01-2011

David Price, Carlsbad, CA US

Patent application numberDescriptionPublished
20120004637DRUG DELIVERY MANAGEMENT SYSTEMS AND METHODS - Various embodiments of a “smart” drug delivery system are provided which includes an add-on module and a reusable or disposable drug pen in conjunction with a data management unit(s) DMU. Upon attachment to the pen, the add-on module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, transmit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reuse of needles, track amount of drug remaining on board the pen or duration of usage of pen with respect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module. Methods of using the drug delivery system are also described.01-05-2012